Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


30.01.2017

1 Alzheimer Dis Assoc Disord
1 Am J Alzheimers Dis Other Demen
1 BMC Neurol
2 Brain
5 Curr Alzheimer Res
1 Dement Geriatr Cogn Disord
15 J Alzheimers Dis
1 J Biol Chem
1 J Neurol
3 Nat Rev Neurol
1 Neurobiol Dis
1 Neuroreport
1 Neurosci Lett
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. VELAYOS-BAEZA A, Danek A
    Chorein Deficiency and Alzheimer Disease: An Intriguing, Yet Premature Speculation.
    Alzheimer Dis Assoc Disord. 2017 Jan 24. doi: 10.1097/WAD.0000000000000186.
    PubMed     Text format    


    Am J Alzheimers Dis Other Demen

  2. GARRE-OLMO J, Vilalta-Franch J, Calvo-Perxas L, Lopez-Pousa S, et al
    A Path Analysis of Dependence and Quality of Life in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2016 Jan 1:1533317516688297.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. LI F, Chen S, Wei C, Jia J, et al
    Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
    BMC Neurol. 2017;17:15.
    PubMed     Text format     Abstract available


    Brain

  4. FAN Z, Brooks DJ, Okello A, Edison P, et al
    An early and late peak in microglial activation in Alzheimer's disease trajectory.
    Brain. 2017 Jan 24. pii: aww349. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. PASSAMONTI L, Vazquez Rodriguez P, Hong YT, Allinson KS, et al
    18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Brain. 2017 Jan 24. pii: aww340. doi: 10.1093.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  6. DECOURT B, Drumm-Gurnee D, Wilson J, Jacobson S, et al
    Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available

  7. KLIMOVA B, Kuca K
    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review Alzheimer's Disease and Chinese Medicine.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available

  8. HULL M, Sadowsky C, Arai H, Le Prince Leterme G, et al
    Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available

  9. FUKAMI Y, Ariga T, Yamada M, Yuki N, et al
    Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available

  10. TERZIOGLU-USAK S, Negis Y, Karabulut DS, Zaim M, et al
    Cellular model of Alzheimer's disease: Abeta1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIbeta and Nurr1 expression.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


    Dement Geriatr Cogn Disord

  11. REISBERG B, Shao Y, Golomb J, Monteiro I, et al
    Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial.
    Dement Geriatr Cogn Disord. 2017;43.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  12. FERRARI L, Huang SC, Magnani G, Ambrosi A, et al
    Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160886.
    PubMed     Text format     Abstract available

  13. LOEWENSTEIN DA, Curiel RE, Wright C, Sun X, et al
    Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160881.
    PubMed     Text format     Abstract available

  14. SUNDERMANN EE, Biegon A, Rubin LH, Lipton RB, et al
    Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160716.
    PubMed     Text format     Abstract available

  15. EBEL DL, Torkilsen CG, Ostrowski TD
    Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160974.
    PubMed     Text format     Abstract available

  16. HADDICK PC, Larson JL, Rathore N, Bhangale TR, et al
    A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160524.
    PubMed     Text format     Abstract available

  17. LINGLER JH, Butters MA, Gentry AL, Hu L, et al
    Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:17-24.
    PubMed     Text format     Abstract available

  18. GOMEZ-RAMOS A, Picher AJ, Garcia E, Garrido P, et al
    Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161053.
    PubMed     Text format     Abstract available

  19. SUHONEN NM, Hallikainen I, Hanninen T, Jokelainen J, et al
    The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160983.
    PubMed     Text format     Abstract available

  20. ONTIVEROS-TORRES MA, Labra-Barrios ML, Diaz-Cintra S, Aguilar-Vazquez AR, et al
    Fibrillar Amyloid-beta Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3xTg-AD Transgenic Mouse.
    J Alzheimers Dis. 2016;52:243-69.
    PubMed     Text format     Abstract available

  21. HORVATH A, Szucs A, Barcs G, Kamondi A, et al
    Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-160994.
    PubMed     Text format     Abstract available

  22. N'SONGO A, Carrasquillo MM, Wang X, Nguyen T, et al
    Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161185.
    PubMed     Text format     Abstract available

  23. TRAMUTOLA A, Pupo G, Di Domenico F, Barone E, et al
    Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
    J Alzheimers Dis. 2016;52:359-71.
    PubMed     Text format     Abstract available

  24. JEFFERSON AL, Gifford KA, Acosta LM, Bell SP, et al
    The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.
    J Alzheimers Dis. 2016;52:539-59.
    PubMed     Text format     Abstract available

  25. SANDERS C, Behrens S, Schwartz S, Wengreen H, et al
    Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.
    J Alzheimers Dis. 2016;52:33-42.
    PubMed     Text format     Abstract available

  26. FERNANDEZ-BLAZQUEZ MA, Avila-Villanueva M, Maestu F, Medina M, et al
    Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:271-81.
    PubMed     Text format     Abstract available


    J Biol Chem

  27. MERCER SW, Wang J, Burke R
    In vivo Modelling of the Pathogenic Effect of Copper Transporter Mutations that cause Menkes and Wilson Disease, Motor Neuropathy and Susceptibility to Alzheimer's Disease.
    J Biol Chem. 2017 Jan 24. pii: jbc.M116.756163. doi: 10.1074/jbc.M116.756163.
    PubMed     Text format     Abstract available


    J Neurol

  28. MALIK GA, Robertson NP
    Treatments in Alzheimer's disease.
    J Neurol. 2017 Jan 24. doi: 10.1007/s00415-017-8395.
    PubMed     Text format    


    Nat Rev Neurol

  29. RIDLER C
    Alzheimer Disease: Misfolded diabetes-mellitus peptide seeds amyloid-beta aggregation.
    Nat Rev Neurol. 2017 Jan 20. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    

  30. WOOD H
    Alzheimer disease: Soluble TREM2 in CSF sheds light on microglial activation in AD.
    Nat Rev Neurol. 2017 Jan 13. doi: 10.1038/nrneurol.2016.
    PubMed     Text format    

  31. REIMAN EM
    Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test.
    Nat Rev Neurol. 2017 Jan 13. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurobiol Dis

  32. WALKER JM, Dixit S, Saulsberry AC, May JM, et al
    Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, beta-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.
    Neurobiol Dis. 2017;100:87-98.
    PubMed     Text format     Abstract available


    Neuroreport

  33. XU LL, Shen Y, Wang X, Wei LF, et al
    Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer's disease.
    Neuroreport. 2017 Jan 21. doi: 10.1097/WNR.0000000000000739.
    PubMed     Text format     Abstract available


    Neurosci Lett

  34. GABRIEL AJ, Almeida MR, Ribeiro MH, Duraes J, et al
    Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Neurosci Lett. 2017 Jan 17. pii: S0304-3940(17)30046.
    PubMed     Text format     Abstract available


    PLoS One

  35. CAI K, Xu H, Guan H, Zhu W, et al
    Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.
    PLoS One. 2017;12:e0170875.
    PubMed     Text format     Abstract available

  36. KASTANENKA KV, Hou SS, Shakerdge N, Logan R, et al
    Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0170275.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: